Avadel Pharmaceuticals PLC (AVDL) — Cash Flow Quality Index
Avadel Pharmaceuticals PLC (AVDL) has a Cash Flow Quality Index of 1162.99x as of September 2025. Operating cash flow of $23.26 Million exceeds net income of $20.00K, indicating high earnings quality where cash backs reported profits. Explore Avadel Pharmaceuticals PLC (AVDL) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Avadel Pharmaceuticals PLC Cash Flow Quality Index (2002–2020)
Historical Cash Flow Quality Index for Avadel Pharmaceuticals PLC across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see AVDL cash flow metrics.
Annual Cash Flow Quality Index for Avadel Pharmaceuticals PLC (2002–2020)
Year-by-year earnings quality comparison for Avadel Pharmaceuticals PLC.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | -6.93x | $-48.73 Million | $7.03 Million | ▼ -2898.9% |
| 2017 | 0.25x | $16.66 Million | $67.25 Million | ▼ -88.0% |
| 2015 | 2.07x | $84.29 Million | $40.66 Million | ▲ +724.4% |
| 2004 | -0.33x | $-4.15 Million | $12.50 Million | ▼ -111.4% |
| 2002 | 2.92x | $8.77 Million | $3.00 Million | — |